Wednesday, October 14, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· May 13, 2026

10 Consumer Discretionary Stocks With Whale Alerts In Today's Session

View original at finance.yahoo.com
10 Consumer Discretionary Stocks With Whale Alerts In Today's Session This whale alert can help traders discover the next big trading opportunities…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • A bearish TSLA call option sweep expiring 05/13/26 traded 351 contracts at $450.00 strike, split into 3 trades, at $158.00/contract, totaling $56.0K. Prior open interest was 15,666; session volume was 339,262 contracts.

    60% confidence
  • A bearish Ford (F) call option sweep expiring 01/15/27 traded 712 contracts at $14.85 strike, split into 6 trades, at $120.00/contract, totaling $85.4K. Prior open interest was 51,195; session volume was 3,478 contracts.

    60% confidence
  • A bullish QS call option trade expiring 05/15/26 traded 499 contracts at $8.00 strike, at $66.00/contract, totaling $32.9K. Prior open interest was 19,589; session volume was 10,128 contracts.

    60% confidence
  • Traders search for circumstances when market estimation of an option diverges heavily from its normal worth, as high trading activity can push option prices to exaggerated or underestimated levels.

    60% confidence
  • Whales are entities with large sums of money whose options transactions are tracked via Benzinga's options activity scanner to help traders discover the next big trading opportunities.

    60% confidence

Data points we hold from this source

Starbucks Corporation · options open interest5800 contracts
Starbucks Corporation · options volume692 contracts
Ford Motor Company · options open interest51195 contracts
Ford Motor Company · options price per contract120.0 USD
Ford Motor Company · options volume3478 contracts
Ford Motor Company · options contracts traded712 contracts
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Clinical Catalyst Season: Big-Pharma Data Flow, Regulatory Milestones, and a Thin AI-Drug Fringe
October 2026 conferences (EASD, IGCS, NACFC, HFSA) are producing a dense run of late-stage readouts from Novo Nordisk, Lilly, Roche, Bayer, Vertex and Galderma. Regulatory milestones are scheduled behind them: the ivonescimab BLA PDUFA date on 2026-11-14, FDA acceptance of Roche's vamikibart BLA, and Scholar Rock's EMA resubmission. The AI-and-finance angle is peripheral. It consists of the AI-designed drug Rentosertib and QAIAx, a speculative microcap whose trial claims (the QIII pilot, anticipated 2027-01-01, and a patent update) are forecasts and filings rather than data, so they warrant skepticism.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,375 source documents archived
Query this data → isubstrate.com